Reuters logo
6 months ago
BRIEF-Alere receives FDA CLIA waiver for Alere i RSV rapid molecular test
March 7, 2017 / 1:16 PM / 6 months ago

BRIEF-Alere receives FDA CLIA waiver for Alere i RSV rapid molecular test

March 7 (Reuters) - Alere Inc -

* Alere receives FDA CLIA waiver for Alere™ i RSV rapid molecular test

* Alere i RSV test has been granted clinical laboratory improvement amendments waiver by FDA for detection of RSV infection in children & adults Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below